Dermata Therapeutics (DRMA) Operating Expenses (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Operating Expenses of $1.9 million for Q1 2026, down 17.67% year-over-year from $2.3 million in Q1 2025, and up 1.37% quarter-over-quarter from $1.9 million in Q4 2025.
Dermata Therapeutics (DRMA) Operating Expenses (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Operating Expenses history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 17.67% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $7.4 million (down 36.82% YoY), while the FY2025 annual figure was $7.8 million, down 37.88% from the prior year.
- Operating Expenses for Q1 2026 stood at $1.9 million, up from $1.9 million in the prior quarter.
- The five-year high for Operating Expenses was $3.2 million in Q3 2024, with the low at $1.7 million in Q4 2022.
- The 5-year median for Operating Expenses is $2.3 million (2023), against an average of $2.3 million.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses soared 105.31% in 2022, then plunged 45.42% in 2025.
- Dermata Therapeutics' Operating Expenses stood at $1.7 million in 2022, then grew by 29.69% to $2.2 million in 2023, then surged by 44.17% to $3.2 million in 2024, then tumbled by 40.62% to $1.9 million in 2025, then increased by 1.37% to $1.9 million in 2026.
- Business Quant data shows DRMA's Operating Expenses at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Jun 30, 2022 | 2.73 Mn |
| Mar 31, 2022 | 2.79 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 1.33 Mn |